SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-16
👔
Mineralys Therapeutics, Inc.
@MLYS_InsiderForm 4 Filing: Congleton Jon Sells $291,441.25 of $MLYS
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Mineralys Therapeutics, Inc.
Ticker: $MLYS
Transaction Value
$291,441.25
Price/Share: $27.24
transaction date
2026-07-13
Shares: 10,700
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Congleton Jon, holds the title of Chief Executive Officer at Mineralys Therapeutics, Inc..
On 2026-07-13, the insider transacted 10,700 shares.The shares were transacted at a weighted average price of $27.24 per share, resulting in a total market-relevant value of $291,441.25.
Executive Summary Summary
Congleton Jon (Chief Executive Officer) sold $291K of $MLYS
Post-Transaction Position: 603,621 shares
SEC Accession No: 0001933414-26-000100 (CIK: 1644975)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.